Listenly

What are the key starting materials in pharmaceutical manufacturing and how do they flow through the global supply chain?

Answered at 5:04 in Why Procurement Can Make or Break a Drug Company · Executive Edge Podcast

— questions searchable right now

What are the key starting materials in pharmaceutical manufacturing and how do they flow through the global supply chain?

Key starting materials (KSMs) are chemicals that go into an active pharmaceutical ingredient (API); they typically originate in China, move to a CDMO for API production in Europe, the U.S., or Japan, then progress to dosage form manufacturing, primary and secondary packaging, and finally distribution.

Dave Stowe on Executive Edge PodcastAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

Key starting materials (KSMs) are chemicals that go into an active pharmaceutical ingredient (API); they typically originate in China, move to a CDMO for API production in Europe, the U.S., or Japan, then progress to dosage form manufacturing, primary and s…

Dave Stowe, Founder and Managing Partner at Adventus · Why Procurement Can Make or Break a Drug Company · Executive Edge Podcast · answer at 5:04

Quote to remember

“There's always this challenge, right? It's a game of capacity management. You know, you can imagine you're buying capacity at the CDMO. They could sell it to somebody else.”

— Dave Stowe

The full answer · about 1 min

Key starting materials (KSMs) are chemicals that go into an active pharmaceutical ingredient (API); they typically originate in China, move to a CDMO for API production in Europe, the U.S., or Japan, then progress to dosage form manufacturing, primary and secondary packaging, and finally distribution.

Key facts

  • 37% of global chemicals in pharmaceutical manufacturing originate from China
  • CDMO biologics manufacturing forecasted at 8 to 12% compound annual growth rate over seven years
  • Drug development timeline: 2 to 5 to 10 years from preclinical through full production
  • Radioisotope half-life example: 5-day half-life requiring overnight shipping from Indiana to patient administration
  • Injectable syringe viscosity requirement: under 5 to 10 milliliters

People, companies and topics mentioned

AdventusCDMO (Contract Development Manufacturing Organization)FDA (Food and Drug Administration)PwCOliver WymanHorizon TherapeuticsPurdue PharmaKSM (Key Starting Materials)

More answers from this episode

 ·  All answers from Executive Edge Podcast →
—
—
0:00
0:00